卡巴西塔塞尔作为对抗西斯普拉丁的膀癌有前途的治疗方法:一项初步研究
Asim Joshi1,2, Abantika Ghosh1,2, Prashant Rai1,2
1Karkinos Healthcare Pvt Ltd, 21st floor, Rupa Renaissance, D33, Turbhe MIDC road, Navi Mumbai, Maharashtra, 400705, India.
Medical oncology (Northwood, London, England)
|August 6, 2024
概括
药物重定向显示出膀癌治疗的前景. 卡巴西塔克塞尔有效抑制了对西斯普拉丁耐药的膀癌细胞,提供了潜在的新疗法,降低了毒性.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 膀癌对全球的健康构成重大负担.
- 西斯普拉丁是标准治疗方法,但它面临着耐药性和毒性方面的挑战.
- 新的治疗策略对于改善患者的治疗结果至关重要.
研究的目的:
- 为了确定有效和少有毒的替代品,西斯替代膀癌症.
- 为了评估FDA批准的抗癌药物对抗抗白抗性膀癌细胞系的疗效.
- 研究药物重定向在克服膀癌药物耐药性的潜力.
主要方法:
- 对FDA批准的抗癌药物的查,用于对西斯普拉丁耐药的膀癌细胞系.
- 根据初始活性选择卡巴西塔克塞尔.
- 详细评估cabazitaxel对细胞增殖,殖民地形成和迁移的影响.
主要成果:
- 卡巴西塔克塞尔在耐药细胞中显著抑制了殖民地形成.
- 卡巴西塔克塞尔有效地抑制了对西斯普拉丁抗性膀癌细胞的增殖.
- 卡巴西塔克塞尔降低了这些耐药癌细胞的迁移能力.
结论:
- 卡巴西塔克塞尔显示出相当大的潜力,作为对抗西斯普拉丁的膀癌的治疗.
- 卡巴西塔克塞尔的药物重定向提供了一个可行的和有效的策略.
- 这种方法可以为传统疗法提供一个具有成本效益的替代方案,减轻耐药性和毒性.
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
01:27Tumor Immunotherapy
497
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
497
01:15Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
156
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
156